Syndax Pharmaceuticals SNDX Other operating expenses
Other operating expenses at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's other operating expenses?
- Syndax Pharmaceuticals (SNDX) reported other operating expenses of $99.07M in Q1 2026.
- How has Syndax Pharmaceuticals's other operating expenses changed year-over-year?
- Syndax Pharmaceuticals's other operating expenses decreased by 4.6% year-over-year, from $103.8M to $99.07M.
- What is the long-term trend for Syndax Pharmaceuticals's other operating expenses?
- Over 4 years (2021 to 2025), Syndax Pharmaceuticals's other operating expenses has grown at a 40.8% compound annual growth rate (CAGR), from $113.49M to $445.68M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.